Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
Nov 21 INCY Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More
Nov 20 RNXT Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
Nov 19 INCY Equities Close Mostly Higher as Nvidia Jumps Ahead of Earnings; Wall Street Tracking Russia-Ukraine Conflict
Nov 19 INCY Equity Markets Close Mixed Ahead of Nvidia Earnings
Nov 19 INCY S&P 500 Gains and Losses Today: Supermicro Roars Back After Compliance Filing
Nov 19 INCY Sector Update: Health Care Stocks Decline
Nov 19 INCY Top Midday Decliners
Nov 19 INCY Equities Mixed Intraday Amid Growing Russia-Ukraine Conflict
Nov 19 INCY Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study
Nov 19 INCY Incyte seesaws on report of potential Merck takeover interest
Nov 19 INCY Incyte Stock Slumps After Firm Scraps Drug, Pauses Enrollment in Other Study
Nov 19 INCY Incyte Is the S&P 500’s Worst Performer Today. What’s Hitting the Stock.
Nov 19 INCY Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
Nov 19 INCY Incyte Faces Challenges but Remains Focused on Strategic Growth
Nov 19 INCY Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.
Nov 19 MIST After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook is Bright
Nov 19 DVAX Dynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To Explode
Nov 19 INCY Incyte sinks on setback for drugs acquired in $750M buyout
Nov 18 INCY Incyte drops 9% after pausing enrollment in study for urticaria asset
Nov 18 INCY Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags